The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients

• Main Authors: Faisal A. Alzahrani (Author), Islam M. Saadeldin (Author), Abrar Ahmad (Author), Dipak Kumar (Author), Esam I. Azhar (Author), Arif Jamal Siddiqui (Author), Bassem Kurdi (Author), Abdulrahim Sajini (Author), Abdulmajeed F. Alrefaei (Author), Sadaf Jahan (Author)
• Format: Book
• Published: Hindawi Limited, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this disease "COVID-19" and declared it a pandemic on March 11, 2020. Many studies have shown that mesenchymal stem cell...